Bayer Aktiengesellscha Valuation
| BAYA Stock | EUR 4.94 0.24 5.11% |
At this time, the firm appears to be overvalued. Bayer Aktiengesellschaft shows a prevailing Real Value of €4.67 per share. The current price of the firm is €4.94. Our model approximates the value of Bayer Aktiengesellschaft from analyzing the firm fundamentals such as Shares Owned By Institutions of 0.10 %, return on equity of 0.13, and Current Valuation of 82.93 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bayer Aktiengesellscha's price fluctuation is relatively risky at this time. Calculation of the real value of Bayer Aktiengesellschaft is based on 3 months time horizon. Increasing Bayer Aktiengesellscha's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bayer stock is determined by what a typical buyer is willing to pay for full or partial control of Bayer Aktiengesellschaft. Since Bayer Aktiengesellscha is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bayer Stock. However, Bayer Aktiengesellscha's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.94 | Real 4.67 | Hype 4.94 | Naive 4.47 |
The real value of Bayer Stock, also known as its intrinsic value, is the underlying worth of Bayer Aktiengesellschaft Company, which is reflected in its stock price. It is based on Bayer Aktiengesellscha's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bayer Aktiengesellscha's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bayer Aktiengesellschaft helps investors to forecast how Bayer stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bayer Aktiengesellscha more accurately as focusing exclusively on Bayer Aktiengesellscha's fundamentals will not take into account other important factors: Bayer Aktiengesellscha Total Value Analysis
Bayer Aktiengesellschaft is currently anticipated to have takeover price of 82.93 B with market capitalization of 55.35 B, debt of 35.55 B, and cash on hands of 8.19 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bayer Aktiengesellscha fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
82.93 B | 55.35 B | 35.55 B | 8.19 B |
Bayer Aktiengesellscha Investor Information
The company has price-to-book (P/B) ratio of 1.32. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bayer Aktiengesellschaft has Price/Earnings To Growth (PEG) ratio of 1.28. The entity last dividend was issued on the 2nd of May 2022. The firm had 400:100 split on the 20th of September 2017. Based on the key measurements obtained from Bayer Aktiengesellscha's financial statements, Bayer Aktiengesellschaft is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Bayer Aktiengesellscha Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bayer Aktiengesellscha has an asset utilization ratio of 36.66 percent. This implies that the Company is making €0.37 for each dollar of assets. An increasing asset utilization means that Bayer Aktiengesellschaft is more efficient with each dollar of assets it utilizes for everyday operations.Bayer Aktiengesellscha Ownership Allocation
Bayer Aktiengesellscha holds a total of 3.93 Billion outstanding shares. Almost 99.9 percent of Bayer Aktiengesellscha outstanding shares are held by general public with 0.1 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bayer Aktiengesellscha Profitability Analysis
The company reported the revenue of 44.08 B. Net Income was 1000 M with profit before overhead, payroll, taxes, and interest of 30.87 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bayer Aktiengesellscha's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bayer Aktiengesellscha and how it compares across the competition.
About Bayer Aktiengesellscha Valuation
The stock valuation mechanism determines Bayer Aktiengesellscha's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bayer Aktiengesellscha. We calculate exposure to Bayer Aktiengesellscha's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bayer Aktiengesellscha's related companies.Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. BAYER ADR is traded on Frankfurt Stock Exchange in Germany.
8 Steps to conduct Bayer Aktiengesellscha's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bayer Aktiengesellscha's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bayer Aktiengesellscha's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bayer Aktiengesellscha's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bayer Aktiengesellscha's revenue streams: Identify Bayer Aktiengesellscha's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bayer Aktiengesellscha's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bayer Aktiengesellscha's growth potential: Evaluate Bayer Aktiengesellscha's management, business model, and growth potential.
- Determine Bayer Aktiengesellscha's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bayer Aktiengesellscha's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Bayer Stock analysis
When running Bayer Aktiengesellscha's price analysis, check to measure Bayer Aktiengesellscha's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer Aktiengesellscha is operating at the current time. Most of Bayer Aktiengesellscha's value examination focuses on studying past and present price action to predict the probability of Bayer Aktiengesellscha's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer Aktiengesellscha's price. Additionally, you may evaluate how the addition of Bayer Aktiengesellscha to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |